FDA warns J&J vaccine plant in South Korea following 2024 inspectionnews2025-09-23T18:54:28+00:00September 23rd, 2025|Endpoints News|
Lilly sets aside $6.5B for new Texas site to make its obesity pill news2025-09-23T17:00:55+00:00September 23rd, 2025|Endpoints News|
FDA hands Scholar Rock a CRL for spinal muscular atrophy drugnews2025-09-23T11:25:22+00:00September 23rd, 2025|Endpoints News|
Eli Lilly sells New Jersey site to Celltrion for $330Mnews2025-09-23T10:59:40+00:00September 23rd, 2025|Endpoints News|
Logistics real estate company Prologis promises £3.9B in UK life sciences investmentnews2025-09-18T14:51:31+00:00September 18th, 2025|Endpoints News|
Leadership changes at Avid Bio and Charles River; Merck KGaA opens €150M Irish sitenews2025-09-18T13:30:05+00:00September 18th, 2025|Endpoints News|
AGC Bio to sell two sites in Colorado, will lay off 278 workers in the processnews2025-09-17T14:41:51+00:00September 17th, 2025|Endpoints News|
GSK budgets $30B to boost US presencenews2025-09-16T23:01:44+00:00September 16th, 2025|Endpoints News|
Eli Lilly picks Virginia for $5B API site as part of $27B US pledgenews2025-09-16T14:30:17+00:00September 16th, 2025|Endpoints News|
Pharma mulls UK divestments as government action lags in life sciencesnews2025-09-15T17:48:49+00:00September 15th, 2025|Endpoints News|
